GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inventionmed SA (WAR:INM) » Definitions » Price-to-Owner-Earnings

Inventionmed (WAR:INM) Price-to-Owner-Earnings : (As of Apr. 17, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Inventionmed Price-to-Owner-Earnings?

As of today (2025-04-17), Inventionmed's share price is zł0.189. Inventionmed does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Inventionmed's Price-to-Owner-Earnings or its related term are showing as below:

During the past 12 years, the highest Price-to-Owner-Earnings of Inventionmed was 54.00. The lowest was 30.67. And the median was 42.00.


WAR:INM's Price-to-Owner-Earnings is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 28.42
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-04-17), Inventionmed's share price is zł0.189. Inventionmed's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was zł-0.02. Therefore, Inventionmed's PE Ratio (TTM) for today is At Loss.

As of today (2025-04-17), Inventionmed's share price is zł0.189. Inventionmed's EPS without NRI for the trailing twelve months (TTM) ended in was zł-0.02. Therefore, Inventionmed's PE Ratio without NRI for today is At Loss.

During the past 12 years, Inventionmed's highest PE Ratio without NRI was 595.00. The lowest was 0.00. And the median was 226.00.


Inventionmed Price-to-Owner-Earnings Historical Data

The historical data trend for Inventionmed's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventionmed Price-to-Owner-Earnings Chart

Inventionmed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 205.25 - - -

Inventionmed Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Inventionmed's Price-to-Owner-Earnings

For the Medical Devices subindustry, Inventionmed's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inventionmed's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inventionmed's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Inventionmed's Price-to-Owner-Earnings falls into.


;
;

Inventionmed Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Inventionmed's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.189/-0.05
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inventionmed  (WAR:INM) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Inventionmed Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Inventionmed's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Inventionmed Business Description

Traded in Other Exchanges
N/A
Address
ul. Bydgoskich, Przemyslowcow 6, Bydgoszcz, POL, 85-862
Inventionmed SA focuses on the development of medical simulators based on VR technology for use in education in esthetic and clinical dermatology. The firm's flagship project consists of TutorDerm, a simulator and an application that allow performing the activities necessary to treat specific dermatological conditions.

Inventionmed Headlines

From GuruFocus

Q3 2021 InMed Pharmaceuticals Inc Earnings Call Transcript

By GuruFocus Research 03-06-2024

InMed Announces Appointment of Chief Operating Officer

By PurpleRose PurpleRose 07-18-2022

Q3 2020 InMed Pharmaceuticals Inc Earnings Call Transcript

By GuruFocus Research 03-06-2024

InMed Submits Form 12b-25

By GlobeNewswire GlobeNewswire 02-10-2023

InMed Announces Results of 2022 Annual General Meeting

By Value_Insider Value_Insider 12-16-2022

InMed Announces Changes to its Board of Directors

By PurpleRose PurpleRose 08-09-2022

InMed Pharmaceuticals Supports Epidermolysis Bullosa Awareness Week

By Value_Insider Value_Insider 10-26-2022